A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine Flexible Dose Regimen In Vulnerable Elderly Patients With Overactive Bladder.

Trial Profile

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial To Evaluate The Efficacy And Safety Of Fesoterodine Flexible Dose Regimen In Vulnerable Elderly Patients With Overactive Bladder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2013

At a glance

  • Drugs Fesoterodine (Primary)
  • Indications Overactive bladder; Urge incontinence
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Aug 2013 Results published in the Journal of Urology.
    • 05 May 2013 Results presented at the 2013 Annual Scientific Meeting of the American Geriatrics Society.
    • 02 May 2012 Results presented at the 2012 Annual Scientific Meeting of the American Geriatrics Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top